Atlas FDA

INTERSTIM THERAPY FOR URINARY CONTROL

FDA premarket approval P970004/S064 · decided 2009-04-30

Approval details

PMA number
P970004
Supplement
S064
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
INTERSTIM THERAPY FOR URINARY CONTROL
Generic name
Stimulator, electrical, implantable, for incontinence
Applicant
Medtronic Neuromodulation
Date received
2008-11-03
Decision date
2009-04-30
Days to decision
178 days
Decision code
APPR
Product code
EZW
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Minneapolis, MN
Statement
APPROVAL FOR CLARIFYING LABELING MODIFICATIONS AND EXTENSION OF THE TINED LEAD TEST IMPLANTATION TO 14 DAYS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SureTune4 Software (DEN210003)Medtronic Neuromodulation2021-08-23